Skip to content
Recall Observatory FDA recall evidence

Drug product

Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy

D-0609-2025

July 09, 2025

Class II

Product summary

Firm
Boothwyn Pharmacy LLC
Event
Event 97202
Status
Ongoing
Classification
Class II
Quantity
648 vials
Official record key
drug-enforcement:D-0609-2025

Official wording

Reason: Subpotent Drug

Code information: 03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent